Tengion IncOver The Counter Market:TNGNQ
- LAST PRICE0.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.0000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Tengion Inc | 40.0 | 0.0x | --- |
Pathfinder Cell Therapy Inc | 670.0 | 0.0x | --- |
FluoroPharma Medical Inc | 3.4K | 0.0x | --- |
Refocus Group Inc | 20.0 | 0.0x | --- |
Arno Therapeutics Inc | 4.9K | 0.0x | --- |
Life Stem Genetics Inc | 24.6K | 0.0x | --- |
Company Information
Tengion, Inc. is a regenerative medicine company focused on discovering, developing, manufacturing and commercializing a range of neo-organs, or products composed of living cells, with or without synthetic or natural materials, implanted or injected into the body to engraft into, regenerate, or replace a damaged tissue or organ. The Company, by using its Organ Regeneration Platform, it creates neo-organs using patient’s own cells. The Company, based on its clinical and preclinical experience is leveraging its Organ Regeneration Platform to develop Neo-Kidney Augment for patients with advanced chronic kidney disease and Neo-Urinary Conduit for bladder cancer patients who are in need of a urinary diversion. The Company’s product candidates are intended to delay or eliminate the need for chronic disease therapies, organ transplantation, and the administration of anti-rejection medications.
Contact Information
- Headquarters
- 3929 Westpoint Blvd., Suite GWINSTON-SALEM, NC, United States 27103
- Phone
- 336-722-5855
- Fax
- 302-655-5049
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $40.00 |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 40.2M |
Tengion Inc does not pay a dividend. | |
Beta | --- |
EPS | $-2.41 |
Book Value | $-2.47 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
